摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 5-(2-chlorophenyl)-3,4-dihydro-2,7-dimethyl-4-oxo-5H-pyrano<2,3-d>pyrimidine-6-carboxylate | 119337-31-4

中文名称
——
中文别名
——
英文名称
ethyl 5-(2-chlorophenyl)-3,4-dihydro-2,7-dimethyl-4-oxo-5H-pyrano<2,3-d>pyrimidine-6-carboxylate
英文别名
ethyl 5-(2-chlorophenyl)-2,7-dimethyl-4-oxo-3,5-dihydro-4H-pyrano[2,3-d]pyrimidine-6-carboxylate;Ethyl 5-(2-chlorophenyl)-2,7-dimethyl-4-oxo-3,5-dihydropyrano[2,3-d]pyrimidine-6-carboxylate
ethyl 5-(2-chlorophenyl)-3,4-dihydro-2,7-dimethyl-4-oxo-5H-pyrano<2,3-d>pyrimidine-6-carboxylate化学式
CAS
119337-31-4
化学式
C18H17ClN2O4
mdl
——
分子量
360.797
InChiKey
GYNNLXRDLUILNT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.28
  • 拓扑面积:
    77
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    ethyl 5-(2-chlorophenyl)-3,4-dihydro-2,7-dimethyl-4-oxo-5H-pyrano<2,3-d>pyrimidine-6-carboxylatepotassium carbonate 、 potassium iodide 作用下, 以 乙醇丙酮甲苯 为溶剂, 反应 1.5h, 生成 ethyl 5-(2-chlorophenyl)-2,7-dimethyl-4-oxo-3-[[1-[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]triazol-4-yl]methyl]-5H-pyrano[2,3-d]pyrimidine-6-carboxylate
    参考文献:
    名称:
    具有4 H-吡喃并[2,3- d ]嘧啶作为潜在分枝杆菌结核蛋白酪氨酸磷酸酶B抑制剂的1,2,3-1 H-三唑的合成,生物学评估和分子对接研究
    摘要:
    由取代的苯甲醛,丙二腈和乙酰乙酸乙酯在三组分反应中合成了一些杂环,即2-氨基-4 H-吡喃-3-腈。通过在浓硫酸作为催化剂的存在下与乙酸酐进行闭环反应,这些杂环随后被转化为4H-吡喃并[2,3- d ]嘧啶环。在无水碳酸钾存在下,使用炔丙基溴在干燥的丙酮中,进行嘧啶-4-酮环上内酰胺NH键的连续烷基化反应。3-炔丙基-4H-吡喃并[2,3- d ]嘧啶化合物的点击化学已通过与四-O-乙酰基-α- d反应而完成-使用金属-有机骨架[受电子邮件保护]作为无水乙醇中的催化剂的吡喃葡萄糖基叠氮化物。筛选所有合成的1 H- 1,2,3-三唑8a-y的体外结核分枝杆菌蛋白酪氨酸磷酸酶B(MtbPtpB)抑制作用。活性最高的化合物8v,8x和8y的动力学研究表明,它们对MtbPtpB酶具有竞争性抑制作用。详细的结构-活性关系(SAR)的体外和计算机模拟研究表明,Arg63氨基酸与阴离子型对羟基的相互作用是通过
    DOI:
    10.1016/j.bmcl.2018.12.009
  • 作为产物:
    参考文献:
    名称:
    Harb, Abdel-Fattah A.; Hesien, Abdel-Haleem M.; Metwally, Saoud A., Liebigs Annalen der Chemie, 1989, p. 585 - 588
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Efficient and Expeditious Synthesis of Pyrano-pyrimidines, Multi-substituted γ-Pyrans, and Their Antioxidant Activity
    作者:Khairy A. M. El-Bayouki、Wahid M. Basyouni、Tamer K. Khatab、Fakhry A. El-Basyoni、Ahmed R. Hamed、Eslam A. Mostafa
    DOI:10.1002/jhet.2019
    日期:2014.1
    An efficient, expeditious catalytic route for the synthesis of ethyl 6‐amino‐5‐cyano‐2‐methyl‐4‐aryl‐4H‐pyran‐3‐carboxylates 2 was achieved via a threecomponent, onepot reaction of malononitrile, ethyl acetoacetate, and various aromatic aldehydes in water as a solvent at room temperature. The key advantages are excellent yield, reaction time, and inexpensive catalyst. Also, cyclization of 4H‐pyrans
    通过三组分单锅丙二腈反应,实现了一种高效,快速的催化路线,用于合成乙基6-基-5-基-2-甲基-4-甲基-4-芳基-4 H-喃-3-羧酸酯2室温下,以为溶剂,乙酰乙酸乙酯和各种芳香醛作为溶剂。关键优势是优异的收率,反应时间和廉价的催化剂。此外,还描述了在乙酸酐存在下使用二氧化硅硫酸将4 H-喃2 2环化为相应的4 H-喃并[2,3- d ]嘧啶3。一些合成的化合物表现出有希望的抗氧化活性。
  • HARB, ABDEL-FATTAH A.;HESIEN, ABDEL-HALEEM M.;METWALLY, SAOUD A.;ELNAGDI,+, LIEBIGS ANN. CHEM.,(1989) N, C. 585-588
    作者:HARB, ABDEL-FATTAH A.、HESIEN, ABDEL-HALEEM M.、METWALLY, SAOUD A.、ELNAGDI,+
    DOI:——
    日期:——
查看更多

同类化合物

叔-丁基2-(甲磺酰)-5,7-二氢螺[吡喃并[4,3-D]嘧啶并-8,3-吡咯烷]-1-甲酸基酯 乙基7'-氨基-6-氟-2,2',4'-三羰基-1,1',2,2',3',4'-六氢螺[吲哚-3,5'-吡喃并[2,3-d]嘧啶]-6'-羧酸酯 7H-吡喃并[2,3-d]嘧啶-7-酮 7H-吡喃并[2,3-d]嘧啶 7,8-二氢-5H-吡喃并[4,3-D]嘧啶-2-胺 5H-吡喃并[4,3-d]嘧啶 5H-吡喃并[2,3-d]嘧啶 2H-吡喃并[2,3-d]嘧啶-6-甲腈,7-氨基-1,3,4,5-四氢-5-(4-甲氧苯基)-2,4-二羰基- 2,4-二氯-7,8-二氢-5H-吡喃[4,3-d]嘧啶 1H-吡喃并[3,4-d]嘧啶 1H-吡喃并[3,2-d]嘧啶 (5S,7R,8S)-2-methylsulfanyl-5,8-dihydro-7-allyloxymethyl-5-methoxy-pyrano[3,4-d]-pyrimidin-8-ol 5-ethyl-2-[(Z)-1-thiophen-3-ylpentylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 5-ethyl-2-[[1-(3-methylbutanoyl)piperidin-4-ylidene]amino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 5-butyl-2-[(E)-1-(4-cyclohexylpiperazin-1-yl)butylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 2,3,3a,9-tetrahydro-5-iodo-2,3,3-trimethylimidazo[5,1-b][1,3]benzoxazin-1-one 2,4-dimethyl-9-methoxy-4,12b-dihydro-1H,7H-chromeno[4',3'-4,5]pyrano[2,3-d]pyrimidine-1,3(2H)-dione 5-methyl-3-{3-[(R)-2-oxo-3-(3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)-oxazolidin-5-yl]-propyl}-1H-quinazoline-2,4-dione 7-amino-2-(benzothiazol-2-ylmethyl)-9-phenylthiazolo[4',5':6,5]pyrano[2,3-d]pyrimidine-8(7H)-one 2-[6-[(2-chlorophenyl)methyl]pyridin-2-yl]-7,8-dihydro-5H-pyrano[4,3-d]pyrimidine 8-amino-2-(methylthio)-5-oxo-6-(pyridin-4-yl)-5,6-dihydro-4H-pyrano[2,3-d][1,3]thiazolo[4,5-b]pyridine-7-carbonitrile 5-(4-chlorophenyl)-1,3,8,8-tetramethyl-7,9-dihydro-5H-chromeno[2,3-d]pyrimidine-2,4,6-trione ethyl 7'-amino-2,4'-dioxo-2'-thioxo-1,1',2,2',3',4'-hexahydrospiroindole-3,5'-pyrano[2,3-d]pyrimidine-6'-carboxylate 8-amino-2-(methylthio)-5-oxo-6-(pyridin-3-yl)-5,6-dihydro-4H-pyrano[2,3-d][1,3]thiazolo[4,5-b]pyridine-7-carbonitrile 7-Amino-4-oxo-5-phenyl-2-thioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carboxylic acid ethyl ester 3-(1H-benzoimidazol-2-yl)-3-butyl-5-methyl-dihydro-furan-2-one 3-(1H-benzoimidazol-2-yl)-3-(2-diethylamino-ethyl)-5-methyl-dihydro-furan-2-one 1-{4-[(1R,9S)-3-((S)-3-methyl-morpholin-4-yl)-12-oxa-4,6-diaza-tricyclo[7.2.1.0-2,7]dodeca-2(7),3,5-trien-5-yl]-phenyl}-3-oxetan-3-yl-urea (S)-6-(4-(4-(3-ethylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenylamino)pyridin-2(1H)-one 3-(1H-benzoimidazol-2-yl)-5-methyl-3-(3-methyl-butyl)-dihydro-furan-2-one 13-(3,4-dimethoxyphenyl)-5,5-dimethyl-2-thioxo-2,5,6,8,9,13-hexahydro-4H-pyrimido[5',4':6,7][1,8]naphthyridino[4,3,2-de]quinazoline-10,12(3a1H,11H)-dione (S)-3-allyl-8-ethyl-4,7-dioxo-2-(phenylcarbamoyl)-4,5,7,8-tetrahydro-3H-pyrano[4,3-d]pyrimidin-8-yl acetate 8-{[(2-bromo-3-methylphenyl)oxy]methyl}-1,3-dimethyl-2,3,4,6-tetrahydro-1H-pyrano[3,2-d]pyrimidine-2,4-dione 9-ethyl-6a-methyl-2-phenyl-8,9-dihydro-oxazolo[2,3-b]pyrimido[4,5-d][1,3]oxazin-5-one (S)-1-cyclobutyl-3-(4-(4-(3-methylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenyl)urea (S)-2-(4-(4-(3-ethylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenylamino)pyrimidin-4(3H)-one (6aRS,10aRS)-4,6,6a,7,8,9,10,10a-octahydro-2,4,6,6-tetramethyl-1H-<2>benzopyrano<3,4-d>pyrimidine-1,3(2H)-dione 5-ethyl-2-[(E)-1-thiophen-3-ylpentylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione N3-(methyl 4-deoxy-α-L-threo-hex-4-enopyranosyluronate)-5-fluorouracil 1-{4-[(1S,9R)-3-((S)-3-methyl-morpholin-4-yl)-12-oxa-4,6-diaza-tricyclo[7.2.1.0-2,7]dodeca-2(7),3,5-trien-5-yl]-phenyl}-3-oxetan-3-yl-urea 4,5-dimethyl-12-(4-methoxyphenyl)-2-thioxo-2,4a,7,8,9,10,11,12-octahydrodipyrimido[4,5-b;4',5'-f] [1,8]naphthyridine-9,11-dione 2-[4-[2-hydroxyethyl(methyl)amino]-2-methyl-7-oxopyrimido[5,4-b][1,4]oxazin-8-yl]acetonitrile 5-ethyl-2-[(Z)-1-thiophen-2-ylethylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione